Table 2.
Clinical features | No. of Cases | Strongly positive cases (%) | χ2 | p-value |
---|---|---|---|---|
Gender | 2.303 | 0.129 | ||
Male | 68 | 31 (45.6) | ||
Female | 22 | 6 (27.3) | ||
Age | 5.148 | 0.023* | ||
<65 | 37 | 10 (27.0) | ||
≥65 | 53 | 27 (50.9) | ||
Histological grade | 1.795 | 0.180 | ||
Grade-I, II | 29 | 9 (31.0) | ||
Grade-III | 61 | 28 (45.9) | ||
Tumor invasion | 2.086 | 0.149 | ||
T1-T2 | 16 | 4 (25.0) | ||
T3-T4 | 74 | 33 (44.6) | ||
LN metastasis | 2.171 | 0.141 | ||
Positive | 37 | 12(86.5) | ||
Negative | 53 | 25(64.2) | ||
Lymphatic invasion | 5.559 | 0.018* | ||
Positive | 66 | 32 (48.4) | ||
Negative | 24 | 5 (31.2) | ||
P53 | 0.008 | 0.927 | ||
Positive | 37 | 15 (40.5) | ||
Negative | 53 | 22 (41.5) | ||
Clinical stage | 8.284 | 0.004** | ||
Stage I | 30 | 6 (20.0) | ||
Stage II, III, IV | 60 | 31 (51.7) |
Note: *Mean p<0.05. **Mean p<0.01. Age: p=0.023; Lymphatic invasion: p=0.018; and Clinical stage: p=0.004.
Abbreviations: LN metastasis, Lymph node metastasis.